Notes / Company

Sai Parenteral's Ltd.

SAIPARENT BSE 544742 ISIN INE0H9F01037 Pharmaceuticals

Fundamentals

Market cap: ₹2,586 cr
P/E: 181.35×
ROE: 15.16%
Debt / equity: 1.00
52-week range: 400.00 — 622.80

Research on Tijori Finance

Company snapshot

Sai Parenteral's Ltd.

Pharmaceuticals

₹2,697 cr

P/E 189.14×

Latest quarter · Mar 2026

Sales₹198 cr

Net profit₹13 cr

Op. margin+13.2%

EPS₹2.98

Strength & growth

Debt / equity1.00×

Current ratio1.23×

The timeline — 2 notes on Sai Parenteral's Ltd.

July 2026

01 Jul 26 · 4:38 PM IST Alert

Alert · Order Wins · Small cap

Sai Parenterals locks in ₹1,300-cr Australian OTC deal, 3.4x annual revenue

The 7.5-year exclusive supply contract validates the Noumed acquisition and provides transformational scale for the ₹2,586-cr market-cap company.

May 2026

27 May 26 · 4:52 PM IST Brief

Brief · Earnings · Small cap

Sai Parenterals sees ₹750 cr revenue this year, will carry peak debt of ₹319 cr

Management guided for ₹750 crore in revenue and a 17% EBITDA margin in FY27, a year it calls the peak for debt as it spends ₹440 cr on capex.

Verify on exchange BSE filings for SAIPARENT NSE filings for SAIPARENT Tijori Finance company page